Thousands of heart patients help scientists predict who will benefit from ablation
NCT ID NCT02404415
First seen Apr 10, 2026 · Last updated May 24, 2026 · Updated 3 times
Summary
This study is a registry that collects medical information and blood samples from over 2,400 people who are scheduled for a procedure called atrial fibrillation (AF) ablation. The goal is to find out which factors—like genetics or blood markers—can predict whether the procedure will work well. This research does not test a new treatment but aims to improve future patient care and understand the causes of AF.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37232, United States
Conditions
Explore the condition pages connected to this study.